U.S. Industrials Stock News

NasdaqGS:MYGN
NasdaqGS:MYGNBiotechs

Why Myriad Genetics (MYGN) Is Down 49.0% After Cutting 2026 Revenue Outlook On Prenatal Weakness

In late July 2026, Myriad Genetics reported second-quarter results showing revenue of US$190.7 million versus US$213.1 million a year earlier, alongside a reduced full-year 2026 revenue outlook of US$770 million to US$790 million due to weaker Prenatal Health test volumes and more cautious assumptions for revenue per test. Despite the revenue decline, the company’s net loss narrowed sharply to US$43.2 million from a very large loss a year ago, highlighting significant cost or non-operational...
NYSE:H
NYSE:HHospitality

Hyatt Hotels (H) Updates Guidance And Buybacks, Is The Stock Still Undervalued?

Q2 results and capital return actions in focus for Hyatt Hotels stock Hyatt Hotels (H) has drawn investor attention after its second quarter 2026 earnings, the Board-approved third quarter dividend, an updated full-year net income outlook, and progress on a multi-year share repurchase program. See our latest analysis for Hyatt Hotels. Despite Q2 earnings, guidance and capital returns in focus, Hyatt Hotels shares have pulled back recently, with the 30 day share price return down 8.8% and the...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Why Core Scientific (CORZ) Is Down 8.9% After Massive AMD AI Data Center Deal And $1.16 Billion Loss

In late July 2026, Core Scientific, Inc. reported Q2 2026 revenue of US$164.2 million alongside a net loss of US$1.16 billion, and announced a large‑scale AI infrastructure partnership with Advanced Micro Devices, Inc. involving up to 2.5 gigawatts of potential data center capacity and related stock warrants for Advanced Micro Devices, Inc. Core Scientific, Inc. also added veteran technology executive Mark W. Adams to its expanded seven‑member Board of Directors, strengthening oversight as...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

ANI Pharmaceuticals Stock And 2 U.S. Pharma Names Tied To Tariff Upside

Tariffs on Canadian imports and higher taxes on generic drugs are shaking up expectations for costs and pricing across healthcare. For U.S. specialty pharmaceutical manufacturers, this mix of pressure and opportunity can be important. Some companies may face higher input costs. Others with more domestic production may see a relative edge if imported generics become more expensive. This article explains how the new trade measures could matter for your portfolio and discusses 3 U.S. specialty...
NYSE:PNC
NYSE:PNCBanks

3 US Bank Stocks Worth Watching If The Fed Hikes Rates Again

With the Federal Reserve sounding more hawkish and futures markets pricing a 72% chance of a rate hike by September, many investors are rethinking where they want their money to work. Higher expected yields on safer assets can change the appeal of riskier choices, including Bitcoin and some growth stocks. In this environment, large U.S. value stocks with lower volatility and modest P/E and P/B ratios can look interesting to some investors. This article walks through 3 U.S. large cap value...
NYSE:LOMA
NYSE:LOMABasic Materials

Is Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) Fully Valued At $11.48?

Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) came into focus after a recent share price move, with the stock closing at $11.48. Investors may now reassess its longer term return profile. See our latest analysis for Loma Negra Compañía Industrial Argentina Sociedad Anónima. The recent move to a share price of $11.48 comes after a mixed run, with the 90 day share price return of 8.20% set against a year to date decline of 10.87%. The 5 year total shareholder return of...
NYSE:RBC
NYSE:RBCMachinery

RBC Bearings (RBC) Is Down 7.4% After Strong Q1 Results And Double-Digit Q2 Sales Guidance

RBC Bearings Incorporated has reported its fiscal first-quarter 2027 results, with net sales rising to US$519.5 million and net income to US$101.5 million, and has issued second-quarter guidance calling for net sales between US$505.0 million and US$515.0 million, implying double-digit year-over-year growth. The combination of strong Aerospace & Defense demand, broad-based Industrial segment growth, and guidance that points to continued operational momentum highlights how current end-market...
NYSE:CWT
NYSE:CWTWater Utilities

California Water Service Group (CWT) Could Be 3% Undervalued On Q2 Earnings Growth

California Water Service Group (CWT) reported second quarter results that attracted investor attention, with higher sales, net income, and earnings per share compared with the same period a year earlier. See our latest analysis for California Water Service Group. At a share price of $50.11, California Water Service Group has seen a 90 day share price return of 18.3% and a year to date share price return of 16.7%, while the 1 year total shareholder return of 10.8% contrasts with a 5 year total...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

Is American Superconductor (AMSC) Undervalued After Its Largest Mining Order Yet?

American Superconductor’s latest mining order puts recent stock performance in focus American Superconductor (AMSC) recently announced a US$25 million turnkey order from a North American utility for a large mining project. This contract is the company’s largest individual mining development order to date. The integrated solution will combine STATCOM technology, capacitor banks, shunt reactors and a 138kV transformer with associated switchgear, protection and control systems. Delivery is...
NasdaqGS:KHC
NasdaqGS:KHCFood

Kraft Heinz Stock And 2 Consumer Names Screening For Tariff Reshoring Exposure

Tariffs on Canadian dairy, alcohol, and autos are reshaping expectations for cross border trade, and that puts the spotlight on U.S. Domestic Manufacturing stocks with direct or indirect exposure to this news. The new 50% tariffs and the risk of retaliation could shift where goods are produced, how supply chains are structured, and which companies gain or lose pricing power. This article looks at three stocks from the U.S. Domestic Manufacturing screener that appear to be positively exposed...
NYSE:LVS
NYSE:LVSHospitality

Does Las Vegas Sands' (LVS) Expanded Buyback Plan Redefine Its Capital Allocation Story?

In July 2026, Las Vegas Sands Corp. reported second-quarter 2026 results showing slightly lower quarterly sales and net income year on year, alongside stronger six-month revenue and earnings, while also affirming a quarterly dividend of US$0.30 per share. At the same time, the company completed a long-running US$8.07 billion buyback program and increased its remaining repurchase authorization to US$6.00 billion through 2029, highlighting an ongoing commitment to returning capital to...
NYSE:CBU
NYSE:CBUBanks

Is Community Financial System (CBU) Fully Priced Following Earnings And Dividend News?

Community Financial System (CBU) has drawn fresh investor attention after releasing second quarter 2026 results, reporting net income of US$61.33 million, lower net charge offs, updated buyback activity, and a new quarterly dividend declaration. See our latest analysis for Community Financial System. Community Financial System's recent earnings, buyback activity, and dividend increase come against a share price of US$64.81 that is modestly lower over the past month yet still ahead year to...
NYSE:LOB
NYSE:LOBBanks

How Investors Are Reacting To Live Oak Bancshares (LOB) Strong Q2 Earnings And Lower Credit Costs

In July 2026, Live Oak Bancshares, Inc. reported second-quarter 2026 results showing net interest income of US$125.34 million and net income of US$36.8 million, both higher than the same period a year earlier, with basic earnings per share from continuing operations rising to US$0.75. Alongside this earnings strength, the bank’s net charge-offs fell to US$24,162,000 from US$31,445,000 a year before, highlighting an improvement in credit costs that could be particularly important for a...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

Digital Payment Update - XTransfer Recognized as Leading Innovator in Global Payments

XTransfer, a leading B2B cross-border trade payment platform, has been named to CNBC's 2026 list of the World's Top Fintech Companies in the Payments Segment, highlighting its growing impact in the digital payments landscape. This recognition underscores the company's commitment to providing secure and efficient cross-border payment solutions for SMEs, thereby addressing the complexities of international financial operations. XTransfer's inclusion in this prestigious list, compiled with...
NYSE:ATO
NYSE:ATOGas Utilities

Defensive Dividend Stocks Investors May Revisit After The Fed Shock

The latest Federal Reserve meeting kept interest rates on hold but still triggered the Dow’s worst single-session drop in over a year and exposed rare internal division at the FOMC. With inflation at 4.2% and pressure building on long-term Treasury yields, many investors are reassessing how much risk they want to carry in rate sensitive areas of the market. This article looks at three dividend paying stocks from our Defensive Dividend Stocks screener that appear closely tied to these cross...
NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

Euronet Worldwide (EEFT) Earnings Slip As Its Digital Payments Narrative Still Points Above Fair Value

Euronet Worldwide earnings and buyback activity in focus Euronet Worldwide (EEFT) reported second quarter 2026 results that combined higher sales with lower profitability, while also updating investors on progress under its multi year share repurchase program. Sales for the quarter reached US$1,108.4 million compared with US$1,074.3 million a year earlier. Net income was US$77.4 million versus US$97.6 million, with diluted earnings per share from continuing operations at US$1.71 compared with...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Eli Lilly Stock Leads 3 Pharma Picks As Merger Talk Shakes Big Drugmakers

The latest merger speculation swirling around AstraZeneca and Bristol Myers Squibb has pushed large cap pharma stocks back into the spotlight. Sharp price moves, including AstraZeneca’s intraday fall of up to 7% and a 6% premarket jump for Bristol Myers, show how quickly sentiment can shift when potential mega deals hit the headlines. For investors, this kind of disruption can surface both opportunities and risks. This article looks at 3 stocks from a Healthcare screener that are exposed to...
NYSE:ATHM
NYSE:ATHMInteractive Media and Services

Autohome (ATHM) Faces A 12% Fair Value Gap After $400 Million Buyback

Autohome (NYSE:ATHM) has announced a new share repurchase program of up to US$400 million. The program has been authorized by its Board and is set to run for 12 months, funded entirely from existing cash reserves. See our latest analysis for Autohome. The buyback news lands after a strong short term share price run for Autohome, with a 7 day share price return of 10.0% and a 30 day return of 21.63% helping to lift the 90 day share price return to 24.84%. However, the 1 year total shareholder...
NasdaqGS:CGEM
NasdaqGS:CGEMBiotechs

Will FDA-Backed Registrational Phase 2 for CLN-049 Redefine Cullinan Therapeutics' (CGEM) Narrative?

Cullinan Therapeutics reported that it previously received positive feedback from the U.S. FDA following an End-of-Phase 1 meeting for CLN-049, clearing the way for a potentially registrational Phase 2 trial in relapsed/refractory acute myeloid leukemia and additional combination studies in previously untreated patients. The FDA’s alignment on a seamless Phase 2 design and CLN-049’s Fast Track and Orphan Drug designations together underscore the program’s regulatory momentum in a...
NYSE:QTWO
NYSE:QTWOSoftware

3 Stocks Estimated To Be Up To 44.8% Below Intrinsic Value

In the last week, the United States market has remained flat, yet it has risen by 18% over the past year with anticipated earnings growth of 16% per annum in the coming years. In this environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation.